Immune Contributions to Neurodegenerative Disease

Jennifer Yokoyama, PhD
Associate Professor, Departments of Neurology and Radiology & Biomedical Imaging
University of California, San Francisco

Learning Objectives

• To describe recent advances in Alzheimer's disease genetics in diverse populations.
• To highlight the utility of imaging genetics as a tool for discovery in frontotemporal dementia research.
• To highlight changes in the peripheral immune system in early-onset Alzheimer's disease.

Disclosures

• Planners: Bruce L. Miller, MD; Howard J. Rosen, MD; Manizhe Eslami Amirabadi, MD; Anil Vora; and Janet Allen-Williams have stated they have no relationships to disclose.
• Speaker: Jennifer Yokoyama, PhD, has stated she serves on the Scientific Advisory Board of the Epstein Family Alzheimer's Research Collaboration and receives funding from the NIH; the Rainwater Charitable Foundation; the AFTD Susan Marcus Memorial Fund; the Larry L. Hillblom Foundation; the Bluefield Project to Cure Frontotemporal Dementia; the Alzheimer's Association; the Global Brain Health Institute; the John Douglas French Alzheimer's Foundation; the Mary Oakley Foundation; Alector Therapeutics for Neurodegenerative Diseases; and Transposon Therapeutics, Inc.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered from January 1, 2024, through December 31, 2024. (1 credit per each 1-hour grand rounds session throughout the year).

Questions? Email Manizhe Eslami Amirabadi, MD, at manizhe.eslamiamirabadi@ucsf.edu.

Attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.